GRAFTYS Revenue and Competitors
Estimated Revenue & Valuation
- GRAFTYS's estimated annual revenue is currently $7M per year.
- GRAFTYS's estimated revenue per employee is $251,000
Employee Data
- GRAFTYS has 28 Employees.
- GRAFTYS grew their employee count by -3% last year.
GRAFTYS's People
Name | Title | Email/Phone |
---|
GRAFTYS Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $5M | 40 | -18% | $10M | N/A |
#2 | $24.8M | 99 | 29% | N/A | N/A |
#3 | $84.1M | 0 | N/A | $1.2M | N/A |
#4 | $35.6M | 142 | 30% | N/A | N/A |
#5 | $57.5M | 229 | 6% | N/A | N/A |
#6 | $52.7M | 168 | 25% | $129.6M | N/A |
#7 | $21.1M | 84 | -3% | N/A | N/A |
#8 | $61.2M | 244 | -13% | N/A | N/A |
#9 | $60.6M | 193 | 20% | $115.5M | N/A |
#10 | $56.2M | 179 | -3% | $122.9M | N/A |
What Is GRAFTYS?
Founded in 2005, Graftys develops, manufactures and markets patented synthetic bone biomaterials, in particular new generations of resorbable calcium-phosphate cements, for reconstructive orthopedic surgery. The Company's products are commercialized in more than 25 countries, including Europe and the United States of America, through distribution partnership. The objective of the Company is to expand the Company product lines by offering new versions of existing products and new products with enhanced regenerative properties. The Company is based in Belgium (Wallonia) and France (Nantes and Aix-En-Provence).
keywords:N/AN/A
Total Funding
28
Number of Employees
$7M
Revenue (est)
-3%
Employee Growth %
N/A
Valuation
N/A
Accelerator
GRAFTYS News
... Integra Lifesciences Holdings Corporation, Wright Medical Group, Acumed, Arthrex, CONMED Corporation, Graftys, Isto Biologics, EXACtech.
Graftys (France). Table Of Content : Bone Void Fillers Market Introduction. Market Scope; Market Segmentation; Research Methodology; Definitions...
... Players Wright Medical, Zimmer Biomet, Medtronic, SeaSpine, DePuy Synthes, Stryker, Xtant Medical, Graftys, Arthrex, Biomatlante.
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | N/A | 37 | 32% | N/A |